Neurofibromatosis type 1 with generalized pruritus
DOI:
https://doi.org/10.66344/jpad.13.4.2003.764Keywords:
Neurofibromatosis, pruritusAbstract
Neurofibromatosis is a neurocutaneous condition that can involve almost any organ system. Presenting signs and symptoms may vary widely. We describe a patient who presented with generalized pruritus that was not responding to conventional antihistamines or topical steroids, but responded very well to ketotifen. A brief review of the disorder is also made.References
Morse RP. Neurofibromatosis type 1. Arch Neurol 1999; 56: 364-5.
Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45: 575-8
Karnes PS. Neurofibromatosis: a common neurocutaneous disorder. Mayo Clin Proc 1998; 73:1071-6.
von Recklinghausen FD. Ueber die Multiplen Fibrome der Haut and Ihre Beziehung zu den Multiplen Neuromen. Berlin: Festschrift fur Rudolf Virchow; 1882.
Barker D, Wright E, Nguyen K et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 1987; 236: 1100-3
Gutmann DH: Recent insights into neurofibromatosis type 1: clear genetic progress. Arch Neurol 1998; 55: 778-80
Lazaro C, Ravella A, Gaona A et al. Neurofibromatosis type 1 due to germ line mosaicism in a clinically normal father. N Engl J Med 1994; 331: 1403-7.
Riccardi VM, ed. Neurofibromatosis: phenotype, natural history, and pathogenesis, 2nd edn. Baltimore: John Hopkins University Press; 1992.
Hope DJ, Mulvihill JJ. Malignancy in neurofibromatosis. Adv Neurol 1981; 29: 33-56.
Gutmann DH, Aylsworth A, Carey JC et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis types 1 and 2. JAMA 1997; 278: 51-7.
Nurnberger M, Moll I. Semiquantitative aspect of mast cells and in neurofibromas of neurofibromatosis type 1 and 5. Dermatology 1994; 188: 296-9.
Riccardi VM. Mast cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol 1988; 123: 1011-6.
Riccardi VM. A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching. Arch Dermatol 1993; 129: 577-81.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
